Hertie School, Friedrichstraße 180, Berlin, 10117, Germany.
Non-communicable Diseases Alliance Kenya (NCDAK), KMA Plaza Apartments, Block C Unit 5.2, Mara Road - Upper Hill, P. O Box 5337, Nairobi, Kenya.
Global Health. 2021 Oct 20;17(1):123. doi: 10.1186/s12992-021-00776-3.
In low- and middle-income countries (LMICs), multinational companies have become increasingly involved in addressing public health challenges. Dealing with companies as partners in health sector development creates new challenges for governments. We sought to develop an approach to assess the existence and effectiveness of governance structures that can ensure that industry-led public health initiatives contribute to development.
We developed a governance assessment tool based on the principles of the Paris Declaration for Aid Effectiveness and other related agreements. We applied it to the case of pharmaceutical companies' involvement in the Kenyan response to non-communicable diseases (NCDs). We gathered data for analysis through 46 stakeholder interviews and reviewing documents.
The Kenyan government has informal norms in place regarding program governance and strategy, but it has yet to issue formal regulations. While enabling elements exist that support initiatives to develop in alignment with these norms, implementation is often hindered by a lack of resources. Currently, broad stakeholder support for filling these gaps has created a window of opportunity for action.
The application of the proposed assessment tool illustrates its viability for assisting companies and governments alike in defining governance needs for industry-led public health initiatives. Our findings in Kenya provide example considerations for LMICs working to integrate industry-led public health programs into the health system. Bilateral and multilateral donors also have important roles in strengthening LMICs' capacities to govern multinational corporations' contributions to NCDs in particular, and development in general.
在中低收入国家（LMICs），跨国公司越来越多地参与解决公共卫生挑战。与公司作为卫生部门发展的合作伙伴打交道给政府带来了新的挑战。我们试图开发一种方法来评估可以确保以行业为主导的公共卫生举措有助于发展的治理结构的存在和有效性。
我们根据援助有效性的《巴黎宣言》和其他相关协议的原则制定了一个治理评估工具。我们将其应用于制药公司参与肯尼亚应对非传染性疾病（NCDs）的案例。我们通过 46 个利益相关者访谈和审查文件收集分析数据。
肯尼亚政府在方案治理和战略方面有非正式规范，但尚未发布正式法规。虽然存在支持与这些规范保持一致的发展举措的有利因素，但实施往往因资源匮乏而受阻。目前，广泛的利益相关者支持填补这些空白，为采取行动创造了机会。
拟议评估工具的应用说明了其为协助公司和政府确定以行业为主导的公共卫生举措的治理需求的可行性。我们在肯尼亚的发现为努力将以行业为主导的公共卫生方案纳入卫生系统的 LMICs 提供了范例性考虑。双边和多边捐助者在加强 LMICs 治理跨国公司对 NCDs 特别是对发展的贡献的能力方面也具有重要作用。
